𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease

✍ Scribed by Tarja H. Haapaniemi; Mika A. Kallio; Juha T. Korpelainen; Kalervo Suominen; Uolevi Tolonen; Kyösti A. Sotaniemi; Vilho V. Myllylä

Publisher
Springer
Year
2000
Tongue
English
Weight
232 KB
Volume
247
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early combination therapy with bromocrip
Early combination therapy with bromocriptine and levodopa in parkinson's disease
✍ Dr. Stewart A. Factor; William J. Weiner 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

## Abstract The use of early combination therapy with bromocriptine (Br) and levodopa (LD) in Parkinson's disease is controversial. It has been suggested that treatment with this regimen would prevent or delay the onset of motor fluctuations and dyskinesia. Thus, some have recommended it as a stand

Levodopa response in early Parkinson's d
Levodopa response in early Parkinson's disease
✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Selegiline and mortality in Parkinson's
Selegiline and mortality in Parkinson's disease
✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Comparing bromocriptine effects with lev
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease
✍ Tomoyuki Uchiyama; Ryuji Sakakibara; Tatsuya Yamamoto; Takashi Ito; M Chiharu Ya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract To evaluate the effects of bromocriptine on bladder function in Parkinson's disease (PD) patients and compare these effects with those of (L‐dopa). We recruited 8 patients with PD. Urodynamic study (UDS) was performed before and 1 hour after administering 100 mg L‐dopa/decarboxylase inh